Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02165059 · ClinicalTrials.gov registry record

GI Neuromuscular Pathology Prospective Registry

A clinical trial of Gastroparesis, sponsored by Indiana University.

Recruiting
Registry status
300
Enrollment target
1
Study location

NCT02165059 is a study of Gastroparesis that is actively recruiting participants, run by Indiana University. The registered enrollment target is 300 participants, roughly in line with the 295-participant average among 44 other Gastroparesis trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02165059, a study of Gastroparesis, is actively recruiting participants, sponsored by Indiana University.

RECRUITING
Registry status
300 participants
Enrollment target
1
Study location

Study Summary

In this research study, biopsy samples will be collected to provide more insight into the underlying cause of the motility disorders, help direct further investigation into the cause of the underlying condition, provide future prognosis and predict response to gastric electrical stimulation (GES).

Conditions Studied

Interventions

  • PROCEDURE Surgical Full Thickness Biopsy

Study Locations (1)

Indiana

  • Indiana University Hosptial - Indianapolis

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2013-12
Est. Completion 2025-12

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT02165059

The ClinicalTrials.gov registry entry for NCT02165059 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 295-participant average among 44 other Gastroparesis trials with a reported enrollment target. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Gastroparesis appearing as the primary indexed condition, and to 1 intervention - of which Surgical Full Thickness Biopsy is the first listed.

NCT02165059 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT02165059 about?

NCT02165059 is a clinical study titled "GI Neuromuscular Pathology Prospective Registry". In this research study, biopsy samples will be collected to provide more insight into the underlying cause of the motility disorders, help direct further investigation into the cause of the underlying condition, provide future prognosis and predict response to gastric electrical stimulation (GES).

What is the current status of trial NCT02165059?

This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2013-12. Estimated completion is 2025-12.

What conditions does trial NCT02165059 study?

This clinical trial studies the following conditions: Gastroparesis.

What interventions are being tested in trial NCT02165059?

The interventions under investigation include: Surgical Full Thickness Biopsy (PROCEDURE).

Who is sponsoring clinical trial NCT02165059?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02165059 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gastroparesis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.